These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19674061

  • 21. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y, Komiyama C, Makino M, Takasuna K, Takazawa A, Sakurada S.
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A, Göttlicher M, Nau H.
    ALTEX; 2001 Jun; 18(2):123-6. PubMed ID: 11378687
    [Abstract] [Full Text] [Related]

  • 24. S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.
    Eikel D, Hoffmann K, Zoll K, Lampen A, Nau H.
    Drug Metab Dispos; 2006 Apr; 34(4):612-20. PubMed ID: 16415118
    [Abstract] [Full Text] [Related]

  • 25. The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models.
    White HS, Franklin MR, Kupferberg HJ, Schmutz M, Stables JP, Wolf HH.
    Epilepsia; 2008 Jul; 49(7):1213-20. PubMed ID: 18325020
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
    Kamiński K, Obniska J.
    Bioorg Med Chem; 2008 May 01; 16(9):4921-31. PubMed ID: 18375131
    [Abstract] [Full Text] [Related]

  • 29. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.
    Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ.
    Epilepsia; 2006 Nov 01; 47(11):1841-54. PubMed ID: 17116023
    [Abstract] [Full Text] [Related]

  • 30. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ, Czuczwar P, Cioczek-Czuczwar A, Czuczwar SJ.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):65-74. PubMed ID: 16930590
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures.
    Upton N, Blackburn TP, Campbell CA, Cooper D, Evans ML, Herdon HJ, King PD, Ray AM, Stean TO, Chan WN, Evans JM, Thompson M.
    Br J Pharmacol; 1997 Aug 10; 121(8):1679-86. PubMed ID: 9283703
    [Abstract] [Full Text] [Related]

  • 33. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
    Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P.
    J Med Chem; 1999 Jul 15; 42(14):2582-7. PubMed ID: 10411478
    [Abstract] [Full Text] [Related]

  • 34. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
    White HS, Alex AB, Pollock A, Hen N, Shekh-Ahmad T, Wilcox KS, McDonough JH, Stables JP, Kaufmann D, Yagen B, Bialer M.
    Epilepsia; 2012 Jan 15; 53(1):134-46. PubMed ID: 22150444
    [Abstract] [Full Text] [Related]

  • 35. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
    Spiegelstein O, Yagen B, Levy RH, Finnell RH, Bennett GD, Roeder M, Schurig V, Bialer M.
    Pharm Res; 1999 Oct 15; 16(10):1582-8. PubMed ID: 10554101
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides.
    Librowski T, Kubacka M, Meusel M, Scolari S, Müller CE, Gütschow M.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):138-49. PubMed ID: 17250826
    [Abstract] [Full Text] [Related]

  • 37. Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.
    Isoherranen N, Yagen B, Woodhead JH, Spiegelstein O, Blotnik S, Wilcox KS, Finnell RH, Bennett GD, White HS, Bialer M.
    Br J Pharmacol; 2003 Feb 22; 138(4):602-13. PubMed ID: 12598414
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide.
    Kaufmann D, Yagen B, Minert A, Tal M, Devor M, Bialer M.
    Neuropharmacology; 2008 Mar 22; 54(4):699-707. PubMed ID: 18201732
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and preliminary evaluation of anticonvulsant activity of some [4-(benzyloxy) benzoyl]- and [4-(benzyloxy) benzyl] aminoalkanol derivatives.
    Waszkielewicz AM, Cegła M, Marona H.
    Acta Pol Pharm; 2007 Mar 22; 64(2):147-57. PubMed ID: 17665864
    [Abstract] [Full Text] [Related]

  • 40. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A, Onishi Y, Yagen B, Shimshoni JA, Kaufmann D, Bialer M, Fujiwara M.
    Birth Defects Res A Clin Mol Teratol; 2008 Sep 22; 82(9):610-21. PubMed ID: 18671279
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.